Haresh Mirchandani

Haresh is a proven leader with ~30 years’ experience in the biopharmaceutical industry encompassing deep and diverse management consulting and corporate experience in big and emerging pharma, consumer healthcare, and across functions in business development, commercial and R&D.

Recently retired from Johnson & Johnson as VP, Business Development, Haresh is seasoned in licensing and acquisitions across TAs, and a variety of atypical deal structures and situations, such as external financing, royalty buyout & monetization, distressed asset transactions and public-private partnerships. Earlier, as Director, Strategic Business Analytics, he led global forecasting that facilitated portfolio decisions, internal stage gate reviews as well as licensing and acquisition opportunities.

Prior to J&J, Haresh was a management consultant for Dr. Reddy’s Laboratories (Indian pharmaceutical company). Haresh started his career as GlaxoSmithKline (then SmithKline Beecham) as Senior Scientist, New Product Research within Consumer Healthcare.

Haresh received his B.Pharm. from University of Bombay, Ph.D. from Rutgers University, and MBA from Columbia University.